Stay updated on Eplontersen in ATTR CM: Clinical Trial
Sign up to get notified when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.

Latest updates to the Eplontersen in ATTR CM: Clinical Trial page
- Check6 days agoChange DetectedNo additions or deletions were detected; the study details page content remains unchanged.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check34 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check42 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.3%

- Check56 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check70 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as detailed drug information for Eplontersen. The revision number has also been updated to v3.0.0.SummaryDifference4%

Stay in the know with updates to Eplontersen in ATTR CM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.